Takeda Pharmaceutical Co. Ltd. is to close down one of its main sites in the US, relocating and rationalizing most functions, as it continues to implement restructuring around its planned $62.4bn acquisition of Shire PLC.
Activities at the Deerfield, Illinois site, which acts as the major Japanese firm's main US headquarters and currently employs nearly...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
